Can immunotherapy improve survival in relapsed NSCLC patients?
Characterizing a phenomenon in GBM patients who do not respond well to immunotherapy
Exciting potential of pembrolizumab combined with axitinib for kidney cancer
The BILCAP study: a better overal survivial of biliary tract cancers with adjuvant capecitabine
Influence of new immunotherapy checkpoint inhibitors in melanoma